The Future of Finance is Listening

biotech

653: From Real Estate to the Immune System | Chad Cohen, CFO, Adaptive Biotechnologies

Of all of the business discussions that Chad Cohen has had over the years, few are likely as memorable as the 20-second conversation he had with Zillow CEO Spencer Rascoff about midway into his 9-year career stint with the online real estate company. Cohen joined Zillow back in 2006 as corporate controller, a position that…
Listen to the Episode Below (00:45:53)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

648: A Life Sciences Angler Casts a Sturdy Line | Bill Adams, CFO, NervGen Pharma

It’s a familiar sequence: A strong-minded investor musters the will to lead and steps into the CEO office determined to revitalize a struggling technology company and put it back on the growth track. For Bill Adams, this swift turn of events occurred only a year into his first industry stint as a corporate controller—a career…
Listen to the Episode Below (00:45:12)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

482: When Opportunities Reveal Themselves | Wilco Groenhuysen, CFO, Novocure, Inc.

Near the end of our discussion with CFO Wilco Groenhuysen, he recommends a book while confiding:  "It's not a great book—but it has a big lesson." "Opportunities exist for only for a short time. So when you see an opportunity, grab it and make the best of it," says Groenhuysen, revealing the big lesson and…
Listen to the Episode Below (00:28:36)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

477: A Blueprint for Corporate Finance Success | Ching Jaw, CFO, Cytokinetics

Trained as an engineer, Cytokinetics CFO Ching Jaw methodically designed a blueprint for an early-career transition to corporate finance to fulfill his desire to more broadly help businesses. The plan, and his execution of it, worked exceedingly well. A former platoon commander in the Taiwanese Army, Jaw earned an MBA in finance and general management…
Listen to the Episode Below (00:37:09)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

475: Advancing Product to Enter the Next Stage of Development | Barclay Phillips, CFO, G1 Therapeutics

G1 Therapeutics CFO Barclay “Buck” Phillips set his sights on the CFO position on day one of his very first job back in high school. After he hustled home to share the great news about landing the part-time gig, Phillips’s father, a stock broker, shared some prescient advice: "Son, always make sure you’re the guy…
Listen to the Episode Below (00:50:28)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

473: Guidance for Your C-Suite Ascent | Emma Reeve, CFO, Constellation Pharmaceuticals

A global finance executive with a passion for healthcare, Constellation Pharmaceuticals CFO Emma Reeve offers straightforward advice to aspiring finance chiefs: Continually add new experiences to your backpack and take them with you to your next role. She’s certainly demonstrated that her approach works. Reeve’s 20-plus years of industry experiences extends across pharmaceutical, medical device,…
Listen to the Episode Below (00:35:26)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

466: Energizing the Realm of Early-Stage Pharma | Jeffrey Farrow, CFO, Global Blood Therapeutics (GBT)

An Early Dose of Pharma Start-Up Experience When Global Blood Therapeutics (GBT) CFO Jeffrey Farrow says that he took the corporate-finance career path less traveled, he really means it. As an undergraduate biology major, Farrow and a couple of entrepreneurial-minded postdocs hit upon a way to identify a protein thought to cause Alzheimer’s. The group…
Listen to the Episode Below (00:39:42)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

387: Have Your Team Tell the Story | Jennifer Lew, CFO, Aduro Biotech

Join us when Jennifer Lew explains how the finance team's data insights must not only support executive decision-making, but also help employees across the company "tell the story" and educate customers and key stakeholders about the company's quest to deliver value. "We're constantly thinking about our portfolio of assets and the larger business context for which we're…
Listen to the Episode Below (00:32:12)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

358: One Year After the IPO | Kim Drapkin, CFO, Jounce Therapeutics

Join us when CFO Kim Drapkin explains how she prioritizes the different aspects of her finance leadership role inside the biotech sector and reveals the different experiences that helped to prepare her to lead inside the entrepreneurial world of a mission-driven company. 2018 Milestones “We have our first clinical data coming out this year. So our…
Listen to the Episode Below (00:41:15)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

335: Garnering Investor Recognition: Josh Blacher, CFO, Therapix Biosciences

Join us when Josh Blacher, CFO of Therapix Biosciences Ltd., shares his career-building journey that spans 10 years inside biotech and 14 years inside the capital markets realm. Josh is the former CFO for Galmed Pharmaceuticals and earlier served as Director of Business Development at Teva Innovative Ventures, an early- and midstage investment and in-licensing arm. He also…
Listen to the Episode Below (00:30:20)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify

288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics

To span the realm of opportunities in biotech is to gaze down an infinite loop of possibilities with no beginning or end—a place seemingly at odds with the environs of more practical-minded finance leaders, who find comfort in the finite. Yet few CFOs likely wield greater influence than those who set down roots in the…
Listen to the Episode Below (00:30:25)
Apple PodcastsSpotifyPlayer EmbedShare Leave a ReviewListen in a New WindowDownloadSoundCloudStitcherSubscribe on AndroidSubscribe via RSSSpotifyApple PodcastsAppleSpotify